LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible ...
A Phase II clinical trial investigating the efficacy of the psychedelic compound lysergic acid diethylamide (LSD) in combination with psychotherapy for the treatment of anxiety has reported positive ...
A single dose of LSD eased anxiety symptoms for many folks and the benefits lasted up to three months, a new study reports. Researchers tested several doses of LSD in nearly 200 patients with moderate ...
CLEVELAND, Ohio — The Cleveland Clinic is in the vanguard of a new era of research into psychedelic medicine. The Clinic is the only Ohio site participating in a national study looking at whether LSD, ...
A year after the US Food and Drug Administration (FDA) opened the door to clinical use of lysergic acid diethylamide (LSD), US-based MindMed has launched phase 3 trials in the United States and Europe ...
Source: By IndependentOo, Dominik from Germany, Maximilian IV, Laitche, NASA; composite artwork by Belbury - CC BY 4.0, Wikimedia Working in his lab at the pharmaceutical company Sandoz in 1938, ...
Making a discovery with the potential for innovative applications in pharmaceutical development, a microbiology student has found a long sought-after fungus that produces effects similar to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback